Inhibiting Werner syndrome helicase may offer a new way to target cancers with microsatellite instability

Nature Medicine’s News & Views discusses data on inhibiting the Werner syndrome helicase enzyme in cancers with microsatellite instability. It says the inhibition exploits a new synthetic lethal vulnerability, offering a way to target those tumors.